Nuage Therapeutics appoints Stuart Hughes as CEO and Vanessa Malier as Chair of the Board

Dr. Stuart Hughes has broad R&D leadership experience in a range of settings, having worked in drug discovery across multiple therapeutic areas. Vanessa Malier is a board member and advisor to several biotechs, venture capital and private equity firms.